Evidence map›Paper›PMID 40272482›Full record

ArticleThe Journal of experimental medicine2025

Sympathetic axonogenesis promotes adenoid cystic carcinoma progression.

Chun-Hao Chen, Boris Reva, Nora Katabi, Avishai Wizel, Hongbo Xu, Alan L Ho, Luc G T Morris, Richard L Bakst, Anuraag S Parikh, Yotam Drier and 2 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chun-Hao ChenDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4785-5201
Boris RevaDepartment of Genetics and Genomic Sciences, Mount Sinai Medical Center, New York, NY, USA.ORCID 0000-0001-7934-9667
Nora KatabiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-2974-3046
Avishai WizelThe Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem , Jerusalem, Israel.ORCID 0000-0001-7217-653X
Hongbo XuDepartment of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.ORCID 0009-0001-2091-0023
Alan L HoDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-6885-3742
Luc G T MorrisDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-4417-2280
Richard L BakstDepartment of Radiation Oncology, Mount Sinai Medical Center, New York, NY, USA.ORCID 0000-0001-9279-7878
Anuraag S ParikhDepartment of Otolaryngology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.ORCID 0000-0003-0968-1028
Yotam DrierThe Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem , Jerusalem, Israel.ORCID 0000-0003-1725-2995
Sylvie DebordeDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-6630-4029
Richard J WongDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-6259-7314

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Schwann Cell Reprogramming and Cancer Perineural InvasionR01CA219534 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WONG, RICHARD J · 2017 to 2021
$3.1M
3D Culture Models of Partial-EMT and Its Regulation in Oral Cavity Squamous Cell CarcinomaK08DE033093 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARIKH, ANURAAG SUHRID · 2023 to 2025
$827k
NCI NIH HHS P30 CA008748NCI NIH HHS P30CA008748NCI NIH HHS R01 CA219534NIDCR NIH HHS K08 DE033093NIH HHS R01CA219534
6 · The paper itself

Abstract

Nerves are integral to the adenoid cystic carcinoma (ACC) microenvironment. The strong association of ACC with perineural invasion (PNI) is considered a hallmark of this disease. In human salivary ACC, we identify intratumoral, small-caliber, disorganized sympathetic nerves not observed in other salivary neoplasms. Norepinephrine or sympathetic ganglia explants enhance ACC proliferation in vitro. Two novel orthotopic ACC patient-derived xenograft (PDX) models recapitulate ACC morphology and demonstrate sympathetic innervation. Pharmacologic or surgical blockade of sympathetic nerves decreases ACC PDX growth. Bulk RNA sequencing of salivary ACC reveals correlations between noradrenergic nerve development signatures and worse patient survival. Metastatic ACC foci exhibit lower nerve signature gene expression levels than primary ACC. Sympathetic innervation in ACC is distinct from PNI and reflects tumor axonogenesis driven by noradrenergic neural development programs. These programs support ACC progression, are associated with poor prognosis, and may be inhibited as a therapeutic strategy.

Indexed as

AxonsCarcinoma, Adenoid CysticSalivary Gland NeoplasmsSympathetic Nervous SystemAnimalsCell Line, TumorCell ProliferationDisease ProgressionFemaleHumansMiceNorepinephrineNorepinephrine

Identifiers

PMID40272482
PMCPMC12020745

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.